EUVIMEDEUVIMED entdecken
Leserbrief

Response to “From screening to clinical utility: Validating autoimmune‐associated epilepsy algorithms without antibody confirmation”

Tomásia O de H M Frezatti iD, Américo C Sakamoto iD

Epileptic Disorders · 09.11.2026

DOI: 10.1002/epd2.70473 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Epileptic Disorders, online erschienen am 09.11.2026. Verfasst von Tomásia O de H M Frezatti und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences and Behaviour Sciences, Universidade de São Paulo, Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto, Ribe…. Die Arbeit nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Neurosciences and Behaviour Sciences, Universidade de São Paulo, Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto, Ribeirão Preto, São Paulo, Brazil.

ORCID-Profile: Tomásia O de H M Frezatti, Américo C Sakamoto

Zitieren

APA

Frezatti, T. O. H. M., & Sakamoto, A. C. (2026). Response to “From screening to clinical utility: Validating autoimmune‐associated epilepsy algorithms without antibody confirmation”. Epileptic Disorders. https://doi.org/10.1002/epd2.70473

Vancouver

Frezatti TOHM, Sakamoto AC. Response to “From screening to clinical utility: Validating autoimmune‐associated epilepsy algorithms without antibody confirmation”. Epileptic Disorders. 2026. doi:10.1002/epd2.70473

BibTeX
@article{Frezatti2026,
  author = {Frezatti, Tomásia O de H M and Sakamoto, Américo C},
  title = {Response to “From screening to clinical utility: Validating autoimmune‐associated epilepsy algorithms without antibody confirmation”},
  journal = {Epileptic Disorders},
  year = {2026},
  doi = {10.1002/epd2.70473}
}
Kostenlos starten →